Health Care & Life Sciences » Biotechnology | Catabasis Pharmaceuticals Inc.

Catabasis Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Catabasis Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Federated Kaufmann Fund
8,019,000
11.29%
8,019,000
0.08%
06/29/2018
Federated Kaufmann Small Cap Fund
2,200,000
3.1%
2,200,000
0.1%
06/29/2018
Vanguard Total Stock Market Index Fund
1,605,389
2.25%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
851,114
1.2%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
290,471
0.41%
213,859
0%
07/31/2018
Federated Kaufmann II Fund
215,000
0.3%
215,000
0.08%
06/29/2018
iShares Micro Cap ETF
65,469
0.09%
0
0%
09/06/2018
Vanguard Balanced Index Fund
51,500
0.07%
0
0%
07/31/2018
DFA US Small Cap Portfolio
31,025
0.04%
0
0%
04/30/2018
DFA US Core Equity 1 Portfolio
22,184
0.03%
0
0%
04/30/2018

About Catabasis Pharmaceuticals

View Profile
Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.catabasis.com
Updated 07/08/2019
Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of therapeutics for the treatment of cardiovascular, metabolic and inflammatory diseases. The company was founded by Jill C.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.